Abbott Laboratories
Search results
Find names and safety data sheets for AbbVie products approved in the U.S. for various conditions and stages of life. The product information is governed by local regulations and may vary by country.
- Pharmaceutical Research & Development
AbbVie pharmaceuticals combines advanced science with...
- Pharmaceutical Research & Development
AbbVie | Pharmaceutical Research & Development. Inventing the Future of Medicine. By investing in groundbreaking technologies, we’re on a mission to deliver better solutions to patients. Learn more. Pipeline. Advancing medicines with strong clinical performance in areas of great need. Focus Areas.
At AbbVie, what we do is as important as the way we do it. We go beyond developing medicines, using our resources to improve approaches to health and society in general. We are committed to: Improve health outcomes by advancing patient health and wellbeing through our focus on innovation.
It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and ulcerative colitis . It developed Skyrizi ($7.8 billion in 2023 revenues), an interleukin-23 (IL-23) inhibitor also used to treat autoimmune diseases.
AbbVie is a global biopharmaceutical company that invents and delivers innovative medicines for patients with serious conditions. Learn about AbbVie's science, innovation, partnerships, sustainability and investor resources.
Our Products. A Portfolio of Medicines. We aim to develop innovative therapies for health conditions where there is significant need. Our medicines are approved in individual countries for different uses around the globe. Explore.
AbbVie provides valuable treatment options for serious health challenges in Canada. Browse the list of products by name, category and product monograph or information.
